Biotech

Anatara Lifesciences Ltd (ASX:ANR) Chief Executive Officer Appointment

🕔11/14/2018 8:23:04 AM

Anatara Lifesciences (ASX:ANR) is pleased to announce that it has appointed Mr Steven Lydeamore as Chief Executive Officer, effective as of 3rd December 2018.

Read Full Article▸

Nanollose Ltd (ASX:NC6) Murdoch University Research Agreement For Tissue Engineering

🕔11/13/2018 9:18:23 AM

Nanollose Limited (ASX:NC6) (RFA:N0L) is pleased to announce that it has entered into a research agreement ("Agreement") with Murdoch University to progress the Company's research into the use of its microbial cellulose (MC) as a scaffold in tissue engineering.

Read Full Article▸

Nanollose Ltd (ASX:NC6) Research Agreement Executed With MC Supply Partner

🕔11/5/2018 9:06:01 AM

Nanollose Limited (ASX:NC6) is pleased to announce that in addition to the non-binding Memorandum of Understanding signed in April 2018, a binding research agreement has been executed with Indonesian food producer, PT Supra Natami Utama.

Read Full Article▸

Rhinomed Limited (ASX:RNO) Completes A$5.0 Million Capital Raise

🕔11/2/2018 10:19:59 AM

Rhinomed Limited (ASX:RNO) (OTCMKTS:RHNMF) a nasal delivery technology company has successfully undertaken a placement to institutional and sophisticated domestic and international investors at $0.21 per share. The company sought to raise a minimum of A$3.0 million and up to a maximum of A$5.0m and is pleased to report that demand saw the raise close at $A5.0 million.

Read Full Article▸

Queensland Bauxite Ltd (ASX:QBL) Quarterly Activities Report

🕔11/1/2018 8:11:07 AM

Queensland Bauxite Ltd (ASX:QBL) provides the Company's Quarterly Activities Report.

Read Full Article▸

Queensland Bauxite Ltd (ASX:QBL) Cover Note and Second Supplementary Prospectus

🕔11/1/2018 8:10:02 AM

Queensland Bauxite Ltd (ASX:QBL) provides the Company's cover note and second supplementary prospectus.

Read Full Article▸

Regeneus Ltd (ASX:RGS) Presentation for AusBiotech 2018

🕔10/31/2018 4:26:22 PM

Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, is pleased to announce John Martin, CEO, will present at the AusBiotech 2018 Conference today.

Read Full Article▸